<DOC>
	<DOCNO>NCT00089973</DOCNO>
	<brief_summary>The purpose research study find breast cancer respond investigational drug , Ispinesib . An investigational drug drug approve Food Drug Administration ( FDA ) available research use . In particular , study try find answer follow research question : 1 . Does breast cancer respond Ispinesib ? 2 . What side effect Ispinesib ? 3 . How much Ispinesib blood specific time take ?</brief_summary>
	<brief_title>Study Of Ispinesib In Subjects With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Stage IIIB Stage IV breast cancer Previously receive anthracycline taxane therapy Exclusion criterion : Actively receive anticancer therapy agent ( ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>breast cancer</keyword>
</DOC>